Patents by Inventor Marinos Kallikourdis

Marinos Kallikourdis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PEPTIDE ANTIGENS AND USES THEREOF
    Publication number: 20220323557
    Abstract: The invention provides a new method for identifying peptide antigens relevant to a non-autoimmune disease involving T cell activation as well as novel peptides identified therefrom. The isolated peptides of the invention are useful in the diagnosis, prevention and/or treatment of a cardiovascular disease, more specifically heart failure (HF). The invention further provides a pharmaceutical composition comprising at least one isolated peptide of the invention and a pharmaceutically acceptable carrier, vehicle, excipient and/or diluent. The pharmaceutical composition of the invention is suitable to be orally administered as a tolerizing vaccine.
    Type: Application
    Filed: August 7, 2020
    Publication date: October 13, 2022
    Inventors: Marinos KALLIKOURDIS, Elisa MARTINI, Gianluigi CONDORELLI
  • METHOD OF IDENTIFYING PEPTIDE ANTIGENS AND USES THEREOF
    Publication number: 20220283158
    Abstract: The invention provides a new method for identifying peptide antigens relevant to a non-autoimmune disease involving T cell activation as well as novel peptides identified therefrom. The isolated peptides of the invention are useful in the diagnosis, prevention and/or treatment of a cardiovascular disease, more specifically heart failure (HF). The invention further provides a pharmaceutical composition comprising at least one isolated peptide of the invention and a pharmaceutically acceptable carrier, vehicle, excipient and/or diluent. The pharmaceutical composition of the invention is suitable to be orally administered as a tolerizing vaccine.
    Type: Application
    Filed: August 7, 2020
    Publication date: September 8, 2022
    Inventors: Marinos KALLIKOURDIS, Elisa MARTINI, Gianluigi CONDORELLI
  • Therapeutic use of inhibitors of t cell activation or stimulation
    Patent number: 11344605
    Abstract: The present invention relates to the use of inhibitors of T cell costimulation and/or activation and/or function in the treatment and/or prevention of cardiac pathologies, in particular heart failure diseases, and/or of related symptoms.
    Type: Grant
    Filed: September 27, 2016
    Date of Patent: May 31, 2022
    Assignee: Humanitas Mirasole S.p.A.
    Inventors: Marinos Kallikourdis, Gianluigi Condorelli
  • THERAPEUTIC USE OF INHIBITORS OF T CELL ACTIVATION OR STIMULATION
    Publication number: 20200164031
    Abstract: The present invention relates to the use of inhibitors of T cell costimulation and/or activation and/or function in the treatment and/or prevention of cardiac pathologies, in particular heart failure diseases, and/or of related symptoms.
    Type: Application
    Filed: September 27, 2016
    Publication date: May 28, 2020
    Applicant: HUMANITAS MIRASOLE S.P.A.
    Inventors: Marinos Kallikourdis, Gianluigi Condorelli